Latest Corporate News


Montreal, December 11, 2018- Pharmascience Inc. is proud to announce that once again it has made it to the Top 100 Corporate R&D Spenders 2018 issued by Canada's Top 100 group!

Pharmascience Inc. is ranked 56st in the Corporate R&D Spenders category this year. It is a recognition that is reflective of Pharmascience Inc.’s orientation. “In the market in which we operate, we are fully aware of the importance of always having a head start. It is thanks to our ongoing investments in the modernization of our equipment and facilities and in R&D that we can develop new products and remain leader in the industry.” says David Goodman, Chief Executive Officer for Pharmascience Inc. "We are proud to build on a diversification strategy that has allowed us to evolve over the last 35 years and remain the world leader in pharmaceutical manufacturing!” View the prestigious Canada’s Top 100 Corporate R&D Spenders list.

About Pharmascience Inc.

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Québec with over 1,500 employees proudly headquartered in Montréal. Pharmascience Inc. is a full-service, privately owned pharmaceutical company that has strong roots in Canada and a growing global reach, with product distribution in over 60 countries. Ranked 56th among Canada's top 100 Research & Development (R&D) investors with over $43 million invested in 2017, Pharmascience Inc. is the third-largest manufacturer of over-the-counter generic drugs in the country.

Pharmascience Inc. is a leading manufacturer and marketer of prescription generic, over-the-counter, and behind-the-counter products as well as FDA-approved Canadian-made injectables. The company commercializes nearly 300 product families in 20 different dosage forms for over 2,000 products. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products.

In 2018, Forbes magazine ranked Pharmascience Inc. among its list of top 300 employers. Pharmascience Inc. has strong long-standing philanthropic ties with its communities, both locally and internationally. For more than 20 years, Pharmascience has been working through Health Partners International of Canada (HPIC) as a partner of choice to increase access to medicine. Pharmascience's donations of essential medicine total close to $70 million. 

Back to News